Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 16 of 164 for:    warfarin AND Vitamin K

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters (EPICT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04066764
Recruitment Status : Not yet recruiting
First Posted : August 26, 2019
Last Update Posted : November 15, 2019
Sir Run Run Shaw Hospital
Huadong Hospital
Shanghai Zhongshan Hospital
Shanghai 5th People's Hospital
Yantai Yuhuangding Hospital
Anhui Provincial Hospital
Information provided by (Responsible Party):
Zhenjie Liu, Second Affiliated Hospital, School of Medicine, Zhejiang University

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 1, 2021
Estimated Study Completion Date : October 1, 2022